Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

QUINACRINE for Dermatomyositis: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 8 adverse event reports in the FDA FAERS database where QUINACRINE was used for Dermatomyositis.

Most Reported Side Effects for QUINACRINE

Side Effect Reports % Deaths Hosp.
Drug ineffective 27 22.0% 0 3
Off label use 18 14.6% 0 3
Treatment failure 17 13.8% 0 0
Rash 12 9.8% 0 1
Condition aggravated 11 8.9% 0 1
Headache 11 8.9% 0 0
Abdominal discomfort 10 8.1% 0 1
Diarrhoea 9 7.3% 0 6
Drug ineffective for unapproved indication 9 7.3% 0 0
Infection 9 7.3% 0 0
Lymphopenia 9 7.3% 0 7
Product use in unapproved indication 9 7.3% 0 1
Urticaria 9 7.3% 0 0
White blood cell count decreased 9 7.3% 0 0
Varicella zoster virus infection 8 6.5% 0 5

Other Indications for QUINACRINE

Systemic lupus erythematosus (31) Product used for unknown indication (17) Cutaneous lupus erythematosus (16) Chronic cutaneous lupus erythematosus (15) Subacute cutaneous lupus erythematosus (6)

Other Drugs Used for Dermatomyositis

RITUXIMAB (993) METHOTREXATE (958) HUMAN IMMUNOGLOBULIN G (913) PREDNISONE (744) PREDNISOLONE (652) METHYLPREDNISOLONE (647) MYCOPHENOLATE MOFETIL (636) TACROLIMUS (626) CYCLOPHOSPHAMIDE (511) HYDROXYCHLOROQUINE (419)

Related Pages

QUINACRINE Full Profile All Dermatomyositis Drugs QUINACRINE Demographics QUINACRINE Timeline